Elutia ELUT Revenue Breakdown

NASDAQ ELUT
$0.80 +0.01 (+1.27%)
At close: Oct 1, 2026 · 4:00 PM EDT
Annual revenue breakdowns for Elutia, fiscal 2021 to 2025, as reported in its filings.
Annual history

Elutia Revenue by Segment

Years FY 2023–2025
Lines 2
FY 2025 Total $12.29M

Women'S Health was Elutia’s largest segment in fiscal 2025, bringing in $9.14M of $12.29M (74%).

Elutia revenue by segment, fiscal 2023 to 2025
Segment FY 2023 FY 2025
Women'S Health $10.30M $9.14M
Cardiovascular $5.04M $3.16M
Total $24.75M $12.29M
Totals include 1 discontinued line from earlier reporting.

Elutia revenue by segment: what the figures show

Elutia brought in $12.29M from its two segments in fiscal 2025, the year ended December 31, 2025. Elutia regrouped these segments after fiscal 2023, so the total does not compare directly with that year's $24.75M. Women'S Health was the largest at $9.14M (74.3%), ahead of Cardiovascular at $3.16M (25.7%).

Compared with fiscal 2023, the previous year with figures, Women'S Health fell 11.3% to $9.14M and Cardiovascular fell 37.4% to $3.16M.

Elutia stopped reporting Device Protection as a separate segment after fiscal 2023, when it brought in $9.40M.

Annual history

Elutia Revenue by Product & Service

Years FY 2021–2022
Lines 3
FY 2022 Total $23.85M

Device Protection was Elutia’s largest product and service line in fiscal 2022, bringing in $9.09M of $23.85M (38%).

Elutia revenue by product and service, fiscal 2021 to 2022
Product and Service FY 2021 FY 2022
Device Protection $7.90M $9.09M
Cardiovascular $7.51M $7.28M
Women'S Health $5.05M $7.47M
Total $47.39M $23.85M
Totals include 1 discontinued line from earlier reporting.

Elutia revenue by product and service: what the figures show

Elutia brought in $23.85M from its three product and service lines in fiscal 2022, the year ended December 31, 2022. Elutia regrouped these lines after fiscal 2021, so the total does not compare directly with that year's $47.39M. Device Protection was the largest at $9.09M (38.1%), ahead of Women'S Health at $7.47M (31.3%) and Cardiovascular at $7.28M (30.5%).

Compared with fiscal 2021, Women'S Health grew fastest, up 48.1% to $7.47M, while Cardiovascular fell the most, down 3.0% to $7.28M.

Elutia stopped reporting Orthobiologics as a separate line after fiscal 2021, when it brought in $26.93M.

Questions

Elutia Revenue Breakdown FAQ

How does Elutia make money?

Elutia (ELUT) reports its revenue by segment and by product and service. In fiscal 2025, Women'S Health was its largest segment, bringing in $9.14M (74.3% of the total), followed by Cardiovascular at $3.16M (25.7%).

What is Elutia's largest segment?

Women'S Health was Elutia's largest segment in fiscal 2025, bringing in $9.14M, or 74.3% of the $12.29M total across its two segments.

What is Elutia's largest product and service line?

Device Protection was Elutia's largest product and service line in fiscal 2022, bringing in $9.09M, or 38.1% of the $23.85M total across its three product and service lines.

Where does this revenue breakdown data come from?

Every figure comes from Elutia's annual financial filings, as reported. Each line keeps the name Elutia gives it, and years follow its fiscal calendar.

How far back does Elutia's revenue breakdown go?

Elutia's revenue by segment goes back to fiscal 2023, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.